BioSpace News Archive

Biotech Bay

Agilent Named Company of the Year by Instrument Business Outlook

Agilent Technologies Inc. today announced that it has been selected as 2017 Company of the Year by Instrument Business Outlook (IBO).

January 22, 2018
·
2 min read
Teewinot Life Sciences Corporation’s Subsidiary, Teewinot Technologies, Ltd. Announced Today: Grant of a New Patent With Broad Claims to Biosynthetic Production of Cannabinoid Pharmaceuticals

Teewinot Life Sciences and its wholly owned Irish subsidiary Teewinot Technologies announced today the grant of U.S. Patent No. 9,861,609.

January 22, 2018
·
2 min read
Biotech Beach

IASIS Technologies Release: Clinical Study Shows Good News for Concussion Sufferers

There is good news for those who suffer from concussions.

January 22, 2018
·
2 min read
Novo Nordisk A/S: Share Repurchase Programme – Jan. 22, 2018

Under the programme initiated 1 November 2017, Novo Nordisk will repurchase B shares for an amount up to DKK 4.8 billion in the period from 1 November 2017 to 30 January 2018.

January 22, 2018
·
1 min read
Drug Development

NANOBIOTIX Presents First Promising Data From Phase I/II Liver Cancers Trial of NBTXR3 at the American Society of Clinical Oncology Gastrointestinal Annual Meeting

The product has demonstrated a very good safety profile, with no adverse event (serious or not) related to NBTXR3 occurred and no dose-limiting toxicity (DLT).

January 22, 2018
·
9 min read
ProMIS Neurosciences Issues Response to Recent Market Activity - Jan. 22, 2018

The Company commented on the recent increase in the market price and level of trading volume of its ordinary shares.

January 22, 2018
·
2 min read
Ossur Hf: Transactions in Relation to Share Buyback Program – Jan. 22, 2018

The purpose of the share buyback program is to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Dividend Policy.

January 22, 2018
·
2 min read
Drug Development

Nymox Reports 5-Year Results From Prospective Randomized Controlled Prostate Cancer Study of Fexapotide Triflutate in 146 U.S. Men

After 5 years, the study has now shown that high dose Fexapotide 15mg single dosage treatment resulted in 80% less surgery or radiotherapy associated with Gleason grade progression.

January 22, 2018
·
5 min read
Genetown

ROMIL-UpS ultra lc Solvents and Eluant Mixes

When you need the ultimate quality, take a look at ROMIL-UpS ultra lc solvents and eluants.

January 22, 2018
·
1 min read
Pharm Country

Creative BioMart Enhanced its Metabolism Assays Offering

This enhancement is aimed to provide a more comprehensive list of services for its customers.

January 22, 2018
·
1 min read